Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
9.37M
-
Shares change
-
-104K
-
Total reported value, excl. options
-
$48M
-
Value change
-
-$551K
-
Number of buys
-
4
-
Number of sells
-
-7
-
Price
-
$5.12
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q4 2016
18 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q4 2016.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.37M shares
of 237M outstanding shares and own 3.96% of the company stock.
Largest 10 shareholders include Aisling Capital LLC (3.61M shares), Biomark Capital Management Co. LLC (1.43M shares), Consonance Capital Management LP (1.27M shares), Broadfin Capital, LLC (1.11M shares), PERCEPTIVE ADVISORS LLC (721K shares), FMR LLC (423K shares), FRANKLIN RESOURCES INC (359K shares), VANGUARD GROUP INC (145K shares), Weiss Multi-Strategy Advisers LLC (100K shares), and Iguana Healthcare Management, LLC (100K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.